Care Pathway for Children With Autism Spectrum Disorder Included in the ELENA Cohort

Autism Spectrum Disorder Clinical Trial

— ELENA-SNDS  

Official title:

Care Pathway for Children With Autism Spectrum Disorder Included in the ELENA Cohort : Matching to the National Health Data System

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04292522
• Other study ID #: RECHMPL19_0443-UF7969
• Status: Recruiting
• Start date: February 27, 2020
• Est. completion date: December 31, 2021

Study information

• Verified date: February 2020
• Source: University Hospital, Montpellier
• Contact: Amaria Baghdadli, Professor
• Phone: 04 67 33 98 64
• Email: rech-clinique-autisme[@]chu-montpellier.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Autism Spectrum Disorder (ASD) is lifelong neurodevelopmental disorder that affect social communication and interaction and includes limited and repetitive patterns of behavior (DSM 5). In France, national guidelines about practices recommends early and specific interventions but care pathway are not well described for ASD children. The national health insurance information system record demographic data, medical condition, and reimbursed drug over 98% of the French population. In addition, the ELENA cohort is a large cohort of children with ASD followed for 6 years. Data collected include clinical characteristics of children (IQ, severity of ASD...) and parents (educational level, professional status...).

The first objective of this project is to identify patterns of care trajectories using data from ELENA cohort matched to data from national health insurance information system. Secondary objectives are to examine the links between patterns of care trajectories and clinical characteristics, social environment of autistic children.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 903
• Est. completion date: December 31, 2021
• Est. primary completion date: June 30, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 2 Years and older

Eligibility

Inclusion criteria:

• Included in ELENA Cohort

Exclusion criteria:

• Opposable to reuse data

Related Conditions & MeSH terms

• Autism Spectrum Disorder
• Autistic Disorder
• Child Development Disorders, Pervasive

Locations

Country	Name	City	State
France	Uh Montpellier	Montpellier

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Care pathway	Care pathway will be built from administrative database from birth to 2019	1 day
Primary	Clinical characteristics	Clinical, social and environmental data of children from ELENA cohort	1 day